These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3780834)

  • 1. Use of saliva for monitoring oxcarbazepine therapy in epileptic patients.
    Klitgaard NA; Kristensen O
    Eur J Clin Pharmacol; 1986; 31(1):91-4. PubMed ID: 3780834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of 10-OH-carbazepine, the main metabolite of the antiepileptic oxcarbazepine, from serum and saliva concentrations.
    Kristensen O; Klitgaard NA; Jönsson B; Sindrup S
    Acta Neurol Scand; 1983 Sep; 68(3):145-50. PubMed ID: 6650125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and limitations of oxcarbazepine monitoring using salivary monohydroxycarbamazepine (MHD).
    Miles MV; Tang PH; Ryan MA; Grim SA; Fakhoury TA; Strawsburg RH; DeGrauw TJ; Baumann RJ
    Ther Drug Monit; 2004 Jun; 26(3):300-4. PubMed ID: 15167632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Saliva and plasma levels of carbamazepine have a poor correlation: a pilot study].
    Mennickent S; Vega M; Godoy CG; León MD
    Rev Med Chil; 2007 Mar; 135(3):335-40. PubMed ID: 17505579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of plasma and saliva concentrations of the active monohydroxy metabolite of oxcarbazepine in patients at steady state.
    Cardot JM; Degen P; Flesch G; Menge P; Dieterle W
    Biopharm Drug Dispos; 1995 Oct; 16(7):603-14. PubMed ID: 8785383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gas chromatographic/mass spectrometric assays for oxcarbazepine and its main metabolites, 10-hydroxy-carbazepine and carbazepine-10,11-trans-diol.
    von Unruh GE; Paar WD
    Biomed Environ Mass Spectrom; 1986 Dec; 13(12):651-6. PubMed ID: 2952188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid.
    Tartara A; Galimberti CA; Manni R; Morini R; Limido G; Gatti G; Bartoli A; Strada G; Perucca E
    Br J Clin Pharmacol; 1993 Oct; 36(4):366-8. PubMed ID: 12959317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of oxcarbazepine and 10-hydroxy-carbazepine in the newborn child of an oxcarbazepine-treated mother.
    Bülau P; Paar WD; von Unruh GE
    Eur J Clin Pharmacol; 1988; 34(3):311-3. PubMed ID: 3396622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple method to monitor plasma concentrations of oxcarbazepine, carbamazepine, their main metabolites and lamotrigine in epileptic patients.
    Franceschi L; Furlanut M
    Pharmacol Res; 2005 Apr; 51(4):297-302. PubMed ID: 15683742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary concentrations and plasma protein binding of carbamazepine and carbamazepine 10,11-epoxide in epileptic patients.
    MacKichan JJ; Duffner PK; Cohen ME
    Br J Clin Pharmacol; 1981 Jul; 12(1):31-7. PubMed ID: 7248139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of oxcarbazepine in the dog.
    Schicht S; Wigger D; Frey HH
    J Vet Pharmacol Ther; 1996 Feb; 19(1):27-31. PubMed ID: 8992022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma level monitoring of oxcarbazepine in epileptic patients.
    González-Esquivel DF; Ortega-Gavilán M; Alcántara-López G; Jung-Cook H
    Arch Med Res; 2000; 31(2):202-5. PubMed ID: 10880728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of saliva in monitoring carbamazepine medication in epileptic children.
    Bartels H; Oldigs HD; Günther E
    Eur J Pediatr; 1977 Aug; 126(1-2):37-44. PubMed ID: 902662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein binding of oxcarbazepine and its primary active metabolite, 10-hydroxycarbazepine, in patients with trigeminal neuralgia.
    Patsalos PN; Elyas AA; Zakrzewska JM
    Eur J Clin Pharmacol; 1990; 39(4):413-5. PubMed ID: 2076729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy.
    Lu Y; Fang Y; Wu X; Ma C; Wang Y; Xu L
    Eur J Clin Pharmacol; 2017 Mar; 73(3):307-315. PubMed ID: 27900402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saliva and Plasma Monohydroxycarbamazepine Concentrations in Pediatric Patients With Epilepsy.
    Li RR; Sheng XY; Ma LY; Yao HX; Cai LX; Chen CY; Zhu SN; Zhou Y; Wu Y; Cui YM
    Ther Drug Monit; 2016 Jun; 38(3):365-70. PubMed ID: 26818624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible roles for frequent salivary antiepileptic drug monitoring in the management of epilepsy.
    Herkes GK; Eadie MJ
    Epilepsy Res; 1990 Jul; 6(2):146-54. PubMed ID: 2117529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monitoring therapy by analysis of the drug concentration of saliva].
    Bartels H; Günther E; Wallis S
    Monatsschr Kinderheilkd; 1983 Jan; 131(1):13-6. PubMed ID: 6835213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy.
    Sattler A; Schaefer M; May TW
    Seizure; 2015 Sep; 31():149-54. PubMed ID: 26362393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloud-point extraction for the determination of the free fraction of antiepileptic drugs in blood plasma and saliva.
    Rukhadze MD; Tsagareli SK; Sidamonidze NS; Meyer VR
    Anal Biochem; 2000 Dec; 287(2):279-83. PubMed ID: 11112274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.